Evidence map›Paper›PMID 28275653›Full record

ArticleAnnals of clinical and translational neurology2017

PH20 is not expressed in murine CNS and oligodendrocyte precursor cells.

Mathieu Marella, Joe Ouyang, Jonathan Zombeck, Chunmei Zhao, Lei Huang, Robert J Connor, Kim B Phan, Michael C Jorge, Marie A Printz, Rudolph D Paladini and 9 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Mathieu MarellaHalozyme Therapeutics, Inc. San Diego California.
Joe OuyangHalozyme Therapeutics, Inc. San Diego California.
Jonathan ZombeckBiomodels LLC Watertown Massachusetts.
Chunmei ZhaoHalozyme Therapeutics, Inc. San Diego California.
Lei HuangHalozyme Therapeutics, Inc. San Diego California.
Robert J ConnorHalozyme Therapeutics, Inc. San Diego California.
Kim B PhanHalozyme Therapeutics, Inc. San Diego California.
Michael C JorgeHalozyme Therapeutics, Inc. San Diego California.
Marie A PrintzHalozyme Therapeutics, Inc. San Diego California.
Rudolph D PaladiniHalozyme Therapeutics, Inc. San Diego California.
Arnold B GelbHalozyme Therapeutics, Inc. San Diego California.
Zhongdong HuangHalozyme Therapeutics, Inc. San Diego California.
Gregory I FrostHalozyme Therapeutics, Inc. San Diego California.
Barry J SugarmanHalozyme Therapeutics, Inc. San Diego California.
Lawrence SteinmanUniversity School of Medicine Department of Neurology and Neurological Sciences Beckman Center for Molecular Medicine Stanford University Stanford California.
Ge WeiHalozyme Therapeutics, Inc. San Diego California.
H Michael ShepardHalozyme Therapeutics, Inc. San Diego California.
Daniel C ManevalHalozyme Therapeutics, Inc. San Diego California.
Paula J LapinskasHalozyme Therapeutics, Inc. San Diego California.
Halozyme Therapeutics (United States) · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveExpression of

methodsSteady-state expression of mRNA in OPCs was evaluated by quantitative polymerase chain reaction; the role of PH20 in bovine testicular hyaluronidase (BTH) inhibition of OPC differentiation was explored by comparing BTH to a purified recombinant human PH20 (rHuPH20). Contaminants in commercial BTH were identified and their impact on OPC differentiation characterized.

resultsBTH, but not rHuPH20, inhibited OPC differentiation in vitro. Basic fibroblast growth factor (bFGF) was identified as a significant contaminant in BTH, and bFGF immunodepletion reversed the inhibitory effects of BTH on OPC differentiation.

interpretationWe were unable to detect

Identifiers

PMID28275653
PMCPMC5338182
OpenAlexW2590931340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.